Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection

The unprecedented 2013-2016 West Africa Ebola outbreak accelerated several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several investigational products (IPs) were used throughout the outbreak but were not conclusive for efficacy results. Only the Randomized Controlled Trial (RC...

Descripción completa

Detalles Bibliográficos
Autores principales: Tshiani Mbaya, Olivier, Mukumbayi, Philippe, Mulangu, Sabue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435780/
https://www.ncbi.nlm.nih.gov/pubmed/34526994
http://dx.doi.org/10.3389/fimmu.2021.721328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435780/
https://www.ncbi.nlm.nih.gov/pubmed/34526994
http://dx.doi.org/10.3389/fimmu.2021.721328

Ejemplares similares